ReviewInflammation and regeneration2023

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy.

Takahiro Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.